Loading company…
TetraLogic Research & Development Corp. is a Cambridge, US pharmaceutical company developing novel therapies.
TetraLogic Research & Development Corp. operates in the pharmaceutical sector, researching and developing novel therapies. The company was acquired by TetraLogic Pharmaceuticals in April 2014 for USD 13 mn. TetraLogic Pharmaceuticals, a portfolio company of investors including Amgen Ventures and Pfizer Venture Investments, is headquartered in Cambridge, US. The company is at the Series B stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in